Norges Bank
NPCE icon

Norges Bank’s Neuropace NPCE Stock Holding History

Norges Bank’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
+79,900
New +$1.29M ﹤0.01% 1555
2022
Q2 		– Sell
-58,000
Closed -$476K – 2128
2022
Q1 		$476K Hold
58,000
– – ﹤0.01% 2103
2021
Q4 		$585K Hold
58,000
– – ﹤0.01% 2141
2021
Q3 		$919K Hold
58,000
– – ﹤0.01% 2154
2021
Q2 		$1.38M Buy
+58,000
New +$1.35M ﹤0.01% 2062

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Norges Bank's NPCE Position: Q2 2026 in Review

Norges Bank opened a new position in Neuropace (NPCE) in Q2 2026: 79,900 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #1555 among its holdings. This is a return to the name: Norges Bank previously reported a position in NPCE as recently as Q1 2022.

Norges Bank first reported a position in NPCE in Q2 2021 and has held it in 5 quarters since. The position peaked at $1.38M in Q2 2021. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Norges Bank held 79,900 shares of Neuropace worth $1.27M as of Q2 2026.
  • Neuropace was a new Norges Bank position in Q2 2026.
  • Neuropace made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1555 holding.
  • Norges Bank first reported a position in Neuropace in Q2 2021 and has held it in 5 quarters since.
  • Norges Bank's Neuropace position peaked at $1.38M in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.